LIFE IS RARE Trademark

Trademark Overview


On Friday, March 13, 2026, a trademark application was filed for LIFE IS RARE with the United States Patent and Trademark Office. The USPTO has given the LIFE IS RARE trademark a serial number of 79448587. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, April 23, 2026. This trademark is owned by JCR Pharmaceuticals Co., Ltd.. The LIFE IS RARE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of lysosomal storage diseases; pharmaceutical preparations for the treatment of mucopolysaccharidosis; pharmaceutical preparations for the treatment of Fabry disease; pharmaceutical preparations for the treatment of renal anemia; pharmaceutical preparations for the treatment of growth hormone deficiency in adults and children; pharmaceutical preparations for the treatment of graft-versus-host disease; pharmaceutical preparations for gene therapy for the treatment of genetic diseases or disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for the treatment of rare diseases; biological preparations for use in cell cultures for medical purposes; biological preparations for gene therapy for the treatment of genetic diseases or disorders; enzymes for medical purposes; proteins for medical purposes; hormones for medical purposes; cells for medical use; blood for medical purposes; vaccines; biolo...
life is rare

General Information


Serial Number79448587
Word MarkLIFE IS RARE
Filing DateFriday, March 13, 2026
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateThursday, April 23, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of lysosomal storage diseases; pharmaceutical preparations for the treatment of mucopolysaccharidosis; pharmaceutical preparations for the treatment of Fabry disease; pharmaceutical preparations for the treatment of renal anemia; pharmaceutical preparations for the treatment of growth hormone deficiency in adults and children; pharmaceutical preparations for the treatment of graft-versus-host disease; pharmaceutical preparations for gene therapy for the treatment of genetic diseases or disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for the treatment of rare diseases; biological preparations for use in cell cultures for medical purposes; biological preparations for gene therapy for the treatment of genetic diseases or disorders; enzymes for medical purposes; proteins for medical purposes; hormones for medical purposes; cells for medical use; blood for medical purposes; vaccines; biological tissue cultures for medical purposes; bacteriological preparations for medical purposes; preparations of microorganisms for medical purposes; dietary supplements for human beings; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, May 4, 2026
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameJCR Pharmaceuticals Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events


Event DateEvent Description
Thursday, April 23, 2026SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, May 4, 2026LIMITATION FROM ORIGINAL APPLICATION ENTERED
Monday, May 4, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 4, 2026APPLICATION FILING RECEIPT MAILED